Short description
Suda is focused on oromucosal drug delivery technology to develop pharmaceuticals that improve the health and lifestyle of patients.
Description
Suda Ltd (ASX: SUD) is a drug delivery company utilising proprietary oro-mucosal drug delivery technology to develop low-risk, innovative pharmaceuticals that improve the health and lifestyle of patients. The many potential benefits of administering drugs through the oral mucosa, which is the moist lining of the oral cavity (ie: cheeks, tongue, gums and palate), include ease of use, lower dosage, reduced side effects and faster response time.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Osborne, New South Wales, Australia, Oceania
Founded on
January 1, 1982
Exited on
February 1, 2002
Went public on
February 1, 2002
Stock symbol
SUD
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$56378 - 90123
Sign in for full access